NCT02027428 2020-08-17Safety and Efficacy Study of Abraxane as Maintenance Treatment After Abraxane Plus Carboplatin in 1st Line Stage IIIB / IV Squamous Cell Non-small Cell Lung CancerCelgenePhase 3 Completed427 enrolled 29 charts